This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
How will cuts to Food and Drug Administration staff affect the drug industry? Are companies pushing for too much weight loss from new drugs? And what will bring biotech out of its doldrums? We discuss all that and more on the latest episode of “The Readout LOUD.” Mizuho analyst Jared Holz joins to discuss Adam’s column on biotech’s dark period.
The International Generic and Biosimilar Medicines Association (IGBA) has released a report titled “Gaming the System An Overview of Originator Companies Evergreening Strategies Used to Hinder Access to Generic and Biosimilar Products.” The report outlines market practices that delay the entry of generic and biosimilar medicines, affecting affordability and competition in global healthcare.
Panelists discuss how pharmacists play a crucial role in optimizing health outcomes for women with complex health needs through comprehensive medication management, personalized consultations, and interdisciplinary collaboration. They provide targeted medication therapy, monitor drug interactions, offer medication counseling, manage chronic conditions, support reproductive health, and help patients navigate complex treatment regimens with expertise and compassionate care.
In a rapidly transforming pharmaceutical landscape, securing market access remains paramount. Looking ahead in 2025, several pivotal trends are set to redefine strategies for manufacturers and industry stakeholders. 1. Digital Health: Redefining Patient Support and Engagement Digital health technologies, including AI, are fundamentally changing patient interactions and support services.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
In ongoing trials of Eli Lilly’s next-generation obesity drug, several trial participants are running into an issue they never expected: They are losing too much weight. One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs like Wegovy or Zepbound. Her weight dropped so much that researchers reduced her dose of the treatment, called retatrutide.
Pharmacists are experiencing 'moral injury' with more than half of pharmacy professionals reporting that medicines shortages have impacted their mental health and wellbeing, according to the Royal Pharmaceutical Society (RPS). Its most recent workforce wellbeing survey also found that inadequate staffing was affecting wellbeing for 70% of pharmacy professionals, with just 35% of pharmacists able […] The post Medicines shortages causing 'moral injury', suggests RPS survey appeared
Introduction In an era dominated by digital marketing, traditional advertising remains a vital tool for pharma companies to connect with healthcare professionals (HCPs) and patients alike. While online platforms grow, traditional channels such as print ads, TV commercials, and conferences continue to play a crucial role in boosting brand visibility and driving meaningful engagement.
Introduction In an era dominated by digital marketing, traditional advertising remains a vital tool for pharma companies to connect with healthcare professionals (HCPs) and patients alike. While online platforms grow, traditional channels such as print ads, TV commercials, and conferences continue to play a crucial role in boosting brand visibility and driving meaningful engagement.
In this episode, I’ll discuss the impact of compounded oral vancomycin liquid on hospital readmission for C diff infection. Episode 1001: Saving Money on Oral Vancomycin Is Great For Inpatients But Can Cause Problems On Discharge Subscribe on iTunes , Android , or Stitcher The drug acquisition cost for oral vancomycin capsules is several orders of magnitude larger than for liquid vancomycin prepared from the IV formulation and given via the oral route.
Change has come to the Department of Health and Human Services. With the confirmation of Robert F. Kennedy Jr. as secretary, major shifts in organizational structure, staffing , and policy priorities across the department are already underway. But not all HHS agencies are created equal, and some deserve to be modified with a scalpel rather than a sledgehammer.
Gisela Abbam has been re-appointed as chair of the General Pharmaceutical Council (GPhC) for another term, until 2029. This was announced today at a GPhC committee meeting, following a re-appointment process overseen by two council members at the end of their terms: pharmacist Elizabeth Mailey and layperson Jayne Salt. As part of the process, the […] The post Gisela Abbam reappointed GPhC Chair until 2029 appeared first on The Pharmacist.
Introduction: In the crowded and competitive world of healthcare, how can your brand stand out? Successful pharmaceutical branding is more than just logos and slogansits about building trust, creating loyalty, and differentiating your brand in the market. Patients, providers, and stakeholders alike choose brands they trust. But earning that trust takes strategic branding that goes beyond marketingit requires authenticity, clarity, and consistency.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The fragile X syndrome (FXS) market across the US and Germany is projected to experience explosive growth, quadrupling from $28.7 million in 2025 to $111.9 million by 2030, a CAGR of 31.3 per cent (2025-2030), driven by the anticipated launch of two high-priced targeted therapies for FXS in 2027, according to GlobalData. GlobalDatas latest report, Fragile X Syndrome: Opportunity Assessment and Forecast -Update, anticipates a stable market until the projected US launches of Harmony Biosciences Zy
XRHealth is on a shopping spree, buying three companies in as many years, as it aims to build a leading platform for therapeutic virtual reality. The latest: It’s acquiring RealizedCare, a company that couples immersive experiences with coaches for chronic pain management. XRHealth and RealizedCare own assets for a range of virtual reality headset-based experiences designed to help treat mental health, chronic pain, and other conditions.
If you can find the time, do complete the Pharmacy Pressures Survey this month, says community pharmacy owner Anil Sharma The pharmacy sector has been at crisis point for some time. With staff shortages, rising operational costs, increasing workloads, and the need for more funding, pharmacies are struggling to stay afloat. These challenges impact patient […] The post Your voice, your evidence: Why the Pharmacy Pressures Survey is so important appeared first on The Pharmacist.
Introduction: In 2025, programmatic advertising will continue to redefine how pharmaceutical brands reach healthcare providers (HCPs) and patients. For pharma marketing teams, staying ahead of programmatic advertising trends is not just importantits essential for success. But what trends will shape the future, and how can your team leverage them to drive results?
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
CDMO Live is set to take place on 7-8 May 2025 at Rotterdam’s World Trade Center, bringing together key decision-makers in pharmaceutical outsourcing. As the sector continues its rapid expansion, with a 7 per cent annual growth rate, the event will highlight the increasing reliance on contract development and manufacturing organisations (CDMOs) in bringing new therapies to market.
A committee of experts that advises the Centers for Disease Control and Prevention on vaccine policy — a group believed to be in the crosshairs of Health and Human Services Secretary Robert F. Kennedy Jr. — will not meet for its regularly scheduled February meeting, a senior HHS official confirmed Thursday. The Advisory Committee on Immunization Practices was to meet from Feb. 26 to 28, its first gathering since the Trump administration took office.
A pharmacist partner in a general practice has developed an AI chatbot to help with patient queries on its website. Pharmacist and partner Shilpa Patel developed the chatbot to help relieve winter pressures on her practice. And she used a chatbot that selects information from specific pages on the practice website, including offering advice on […] The post Pharmacist partner launches AI chatbot on GP website appeared first on The Pharmacist.
Introduction: In the fast-evolving world of healthcare marketing, staying ahead requires more than experienceit demands insight. For pharma marketing teams, reading pharmaceutical marketing articles is like having a roadmap to success. These articles highlight industry trends, share real-world case studies, and provide actionable strategies to sharpen your marketing campaigns.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Generative AI (GenAI) is being integrated into India’s pharmaceutical and healthcare sectors, according to EYs report, How much productivity can GenAI unlock in India? The AIdea of India: 2025. The study outlines GenAIs role in enhancing operational efficiency, optimising manufacturing, and streamlining supply chains. The report states that 50 per cent of pharma companies in India have initiated GenAI proof-of-concept projects, with 25 per cent implementing AI solutions in production.
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Bill, baby, bill: Abridge announces $250 million raise Abridge announced a $250 million Series D fundraise co-led by investor Elad Gil and IVP with participation from many other notable venture firms.
Unlocking the Path to Affordable Medications: A Step-by-Step Guide to Generic Drug Approval As a healthcare professional or a patient advocate, you're likely no stranger to the importance of affordable medications. But have you ever wondered what it takes for a generic drug to hit the market? The journey to approval is often shrouded in mystery, but it's a crucial process that affects millions of people worldwide.
The UK government has announced that the Apprenticeship Levy will be replaced by a new Growth and Skills Levy, a move designed to give employers greater control over workforce training. This change aims to address long-standing concerns that the previous system was too rigid, restricting funding primarily to apprenticeships and limiting investment in other essential training programmes.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Orchid Pharma has completed a surprise inspection by the U.S. Food and Drug Administration (USFDA) at its Active Pharmaceutical Ingredient (API) manufacturing facility in Alathur, Tamil Nadu. The inspection took place from 10 February 2025 to 18 February 2025 and resulted in seven minor observations, none related to data integrity. The facility continues to be Indias only USFDA-approved site for Sterile Cephalosporins.
Mainstream policy analysts are convinced that government, and only government, can save us from the monster the U.S. health care system has become. That’s why their recommended solutions to the system’s many problems all have government at their core.
The Unseen Heroes of the Pharmaceutical Industry: Achieving High-Quality Standards in Generic Drugs As we navigate the complex world of healthcare, it's easy to overlook the unsung heroes who work tirelessly behind the scenes to bring affordable, high-quality medications to the masses. I'm talking about the generic drug manufacturers who play a vital role in making life-saving treatments accessible to people worldwide.
Abracadabra! Small pharmacies have ghosted Medicare Part Ds preferred networksno farewell party, no breakup text, just a quiet exit. A few months ago , DCI highlighted how the largest pharmacy chains are participating as preferred cost sharing pharmacies in the 2025 stand-alone prescription drug plan (PDP) networks. Today, we update our exclusive analysis of how smaller pharmacies are participating via their pharmacy services administrative organizations (PSAOs).
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Nectar Life Care has launched a new range of anti-diabetic formulations, including Dapagliflozin under the brand name DAPNEC. With the expiration of API patents, these medicines will now be available at lower costs, improving accessibility while maintaining efficacy. India has a rising demand for diabetes management solutions, with the country often referred to as the Diabetes Capital of the World.
The Maryland House of Delegates has voted overwhelmingly to allow a state board to extend its mandate for lowering prescription drug costs to all residents, not just those employed by government agencies. As a result, the initiative now goes to the state senate for approval, although the timing is unclear. Nonetheless, the 98-to-34 vote was cheered by consumer advocates who hope the Prescription Drug Affordability Board, which is designed to function much like a state utility commission, will us
Recce Pharmaceuticals have announced positive patient data from its phase 2 clinical trial into RECCE 327 (R327), for the treatment of acute bacterial skin and skin structure infections (ABSSSIs), including diabetic foot infections (DFI). R327, a broad-spectrum antibiotic topical gel, was tested in a phase 2 open-label trial that evaluated its safety, tolerability, efficacy and […] The post Recce Pharmaceuticals reports positive phase 2 data for skin infection drug appeared first on Pharma
Introduction: Choosing the right pharmaceutical marketing company is like picking a strategic partnerit can make or break your brands success. In todays competitive market, where digital strategies and patient-centric approaches are essential, having an expert partner is more critical than ever. But how do you know which agency is the perfect fit? With countless companies offering everything from digital advertising to HCP engagement, finding the right one can feel overwhelming.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content